nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—MPO—Calcipotriol—psoriasis	0.422	0.605	CbGbCtD
L-Carnitine—CES1—Mycophenolate mofetil—psoriasis	0.147	0.211	CbGbCtD
L-Carnitine—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0506	0.0726	CbGbCtD
L-Carnitine—SLCO1B1—Cyclosporine—psoriasis	0.0383	0.055	CbGbCtD
L-Carnitine—SLCO1B1—Methotrexate—psoriasis	0.0203	0.0291	CbGbCtD
L-Carnitine—SLC22A8—Methotrexate—psoriasis	0.0187	0.0269	CbGbCtD
L-Carnitine—MPO—IL23-mediated signaling events—IL19—psoriasis	0.00501	0.0768	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IL23R—psoriasis	0.00287	0.0441	CbGpPWpGaD
L-Carnitine—CROT—skin of body—psoriasis	0.0028	0.124	CbGeAlD
L-Carnitine—MPO—IL23-mediated signaling events—IL23A—psoriasis	0.00244	0.0375	CbGpPWpGaD
L-Carnitine—SLC25A20—skin of body—psoriasis	0.00244	0.108	CbGeAlD
L-Carnitine—CPT1A—RORA activates circadian gene expression—CARM1—psoriasis	0.00242	0.0371	CbGpPWpGaD
L-Carnitine—CRAT—skin of body—psoriasis	0.00236	0.104	CbGeAlD
L-Carnitine—CROT—tendon—psoriasis	0.00213	0.0941	CbGeAlD
L-Carnitine—MPO—endothelium—psoriasis	0.00211	0.0933	CbGeAlD
L-Carnitine—XDH—Purine catabolism—CAT—psoriasis	0.00205	0.0315	CbGpPWpGaD
L-Carnitine—SLC25A20—tendon—psoriasis	0.00185	0.0819	CbGeAlD
L-Carnitine—CPT2—skin of body—psoriasis	0.00182	0.0803	CbGeAlD
L-Carnitine—CRAT—tendon—psoriasis	0.0018	0.0795	CbGeAlD
L-Carnitine—XDH—Effects of Nitric Oxide—NOS2—psoriasis	0.00177	0.0272	CbGpPWpGaD
L-Carnitine—SLC22A16—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.00156	0.024	CbGpPWpGaD
L-Carnitine—CPT1A—tendon—psoriasis	0.00146	0.0644	CbGeAlD
L-Carnitine—CPT2—tendon—psoriasis	0.00138	0.0611	CbGeAlD
L-Carnitine—CPT1A—Circadian Clock—CARM1—psoriasis	0.00129	0.0198	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IL17A—psoriasis	0.00114	0.0176	CbGpPWpGaD
L-Carnitine—SLC25A20—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.00112	0.0171	CbGpPWpGaD
L-Carnitine—CPT2—PPARA activates gene expression—CARM1—psoriasis	0.00107	0.0164	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IL12B—psoriasis	0.00106	0.0163	CbGpPWpGaD
L-Carnitine—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.00104	0.016	CbGpPWpGaD
L-Carnitine—MPO—skin of body—psoriasis	0.000902	0.0398	CbGeAlD
L-Carnitine—XDH—Oxidative Stress—CAT—psoriasis	0.000852	0.0131	CbGpPWpGaD
L-Carnitine—XDH—Purine metabolism—CAT—psoriasis	0.000789	0.0121	CbGpPWpGaD
L-Carnitine—CPT1A—PPARA activates gene expression—CARM1—psoriasis	0.000739	0.0113	CbGpPWpGaD
L-Carnitine—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000723	0.0111	CbGpPWpGaD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.000719	0.011	CbGpPWpGaD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—CP—psoriasis	0.000711	0.0109	CbGpPWpGaD
L-Carnitine—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000685	0.0105	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000657	0.0101	CbGpPWpGaD
L-Carnitine—SLC22A4—tendon—psoriasis	0.000627	0.0277	CbGeAlD
L-Carnitine—MPO—IL23-mediated signaling events—NFKBIA—psoriasis	0.000596	0.00916	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—NOS2—psoriasis	0.000596	0.00916	CbGpPWpGaD
L-Carnitine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000579	0.00888	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—NDUFA5—psoriasis	0.000561	0.0086	CbGpPWpGaD
L-Carnitine—SLC22A5—skin of body—psoriasis	0.000545	0.0241	CbGeAlD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000523	0.00802	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL13—psoriasis	0.000519	0.00797	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—CAT—psoriasis	0.000518	0.00796	CbGpPWpGaD
L-Carnitine—CPT1A—AMPK Signaling—LEP—psoriasis	0.000513	0.00787	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—CRP—psoriasis	0.000506	0.00777	CbGpPWpGaD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.000498	0.00765	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—APOE—psoriasis	0.000495	0.0076	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—TYK2—psoriasis	0.000489	0.0075	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—TGFA—psoriasis	0.00048	0.00737	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—NDUFA5—psoriasis	0.000477	0.00732	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CYP2S1—psoriasis	0.000477	0.00732	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—NDUFA5—psoriasis	0.000477	0.00732	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—IL4—psoriasis	0.000476	0.00731	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—ICAM1—psoriasis	0.000465	0.00714	CbGpPWpGaD
L-Carnitine—SLC25A20—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	0.000465	0.00713	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IFNG—psoriasis	0.000457	0.00702	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000444	0.00682	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000444	0.00682	CbGpPWpGaD
L-Carnitine—CPT2—PPARA activates gene expression—PPARG—psoriasis	0.000444	0.00681	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—CD4—psoriasis	0.000442	0.00678	CbGpPWpGaD
L-Carnitine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000435	0.00668	CbGpPWpGaD
L-Carnitine—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	0.000434	0.00667	CbGpPWpGaD
L-Carnitine—SLC22A5—tendon—psoriasis	0.000415	0.0183	CbGeAlD
L-Carnitine—MPO—Selenium Micronutrient Network—CAT—psoriasis	0.000412	0.00632	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—CRP—psoriasis	0.000412	0.00632	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CYP2S1—psoriasis	0.000405	0.00622	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CYP2S1—psoriasis	0.000405	0.00622	CbGpPWpGaD
L-Carnitine—XDH—Nucleotide metabolism—CAT—psoriasis	0.000396	0.00609	CbGpPWpGaD
L-Carnitine—XDH—Oxidative Stress—NFKB1—psoriasis	0.000393	0.00604	CbGpPWpGaD
L-Carnitine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000393	0.00604	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—NFKB1—psoriasis	0.000381	0.00584	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—ICAM1—psoriasis	0.000378	0.00581	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—CP—psoriasis	0.000361	0.00554	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—CAT—psoriasis	0.00036	0.00553	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—IFNG—psoriasis	0.000354	0.00543	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—CARM1—psoriasis	0.000344	0.00529	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—STAT3—psoriasis	0.000342	0.00525	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—CRP—psoriasis	0.000327	0.00502	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL10—psoriasis	0.000325	0.00498	CbGpPWpGaD
L-Carnitine—CES1—Fluoropyrimidine Activity—TP53—psoriasis	0.000308	0.00472	CbGpPWpGaD
L-Carnitine—CPT1A—PPARA activates gene expression—PPARG—psoriasis	0.000308	0.00472	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—NDUFA5—psoriasis	0.000307	0.00471	CbGpPWpGaD
L-Carnitine—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	0.000301	0.00462	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—ICAM1—psoriasis	0.000301	0.00461	CbGpPWpGaD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	0.000299	0.0046	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—TNF—psoriasis	0.000296	0.00454	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—NFKB1—psoriasis	0.000294	0.00452	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—IFNG—psoriasis	0.000288	0.00442	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000286	0.0044	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—CRP—psoriasis	0.000286	0.00439	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—CP—psoriasis	0.000263	0.00404	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—ICAM1—psoriasis	0.000263	0.00403	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYP2S1—psoriasis	0.000261	0.00401	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.00025	0.00383	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—NFKB1—psoriasis	0.00024	0.00368	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IL6—psoriasis	0.000239	0.00367	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CARM1—psoriasis	0.000233	0.00357	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—CD4—psoriasis	0.000229	0.00352	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—TNF—psoriasis	0.000229	0.00352	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—IFNG—psoriasis	0.000229	0.00351	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—LEP—psoriasis	0.000218	0.00335	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.000218	0.00334	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NDUFA5—psoriasis	0.000213	0.00327	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000212	0.00326	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000212	0.00326	CbGpPWpGaD
L-Carnitine—CPT1A—AMPK Signaling—TP53—psoriasis	0.000209	0.00321	CbGpPWpGaD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	0.000207	0.00319	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—NOS2—psoriasis	0.000203	0.00312	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—IFNG—psoriasis	0.0002	0.00307	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000198	0.00305	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CARM1—psoriasis	0.000198	0.00304	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CARM1—psoriasis	0.000198	0.00304	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—CP—psoriasis	0.000198	0.00303	CbGpPWpGaD
L-Carnitine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000191	0.000889	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—NFKB1—psoriasis	0.00019	0.00292	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—PPARG—psoriasis	0.00019	0.00292	CbGpPWpGaD
L-Carnitine—Convulsion—Hydrocortisone—psoriasis	0.00019	0.000881	CcSEcCtD
L-Carnitine—Hypertension—Hydrocortisone—psoriasis	0.000189	0.000878	CcSEcCtD
L-Carnitine—Vomiting—Hydroxyurea—psoriasis	0.000189	0.000876	CcSEcCtD
L-Carnitine—Haemoglobin—Prednisone—psoriasis	0.000188	0.000874	CcSEcCtD
L-Carnitine—Haemorrhage—Prednisone—psoriasis	0.000187	0.000869	CcSEcCtD
L-Carnitine—Rash—Hydroxyurea—psoriasis	0.000187	0.000869	CcSEcCtD
L-Carnitine—Anorexia—Mycophenolate mofetil—psoriasis	0.000187	0.000868	CcSEcCtD
L-Carnitine—Dermatitis—Hydroxyurea—psoriasis	0.000187	0.000868	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—TNF—psoriasis	0.000186	0.00286	CbGpPWpGaD
L-Carnitine—Myalgia—Hydrocortisone—psoriasis	0.000186	0.000866	CcSEcCtD
L-Carnitine—Headache—Hydroxyurea—psoriasis	0.000186	0.000863	CcSEcCtD
L-Carnitine—Anxiety—Hydrocortisone—psoriasis	0.000186	0.000863	CcSEcCtD
L-Carnitine—Vertigo—Triamcinolone—psoriasis	0.000185	0.00086	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.000185	0.00284	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.000185	0.00284	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—IL6—psoriasis	0.000185	0.00284	CbGpPWpGaD
L-Carnitine—Hypotension—Mycophenolate mofetil—psoriasis	0.000183	0.000851	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000183	0.000851	CcSEcCtD
L-Carnitine—Insomnia—Cyclosporine—psoriasis	0.000182	0.000845	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—CYP2S1—psoriasis	0.000181	0.00278	CbGpPWpGaD
L-Carnitine—Paraesthesia—Cyclosporine—psoriasis	0.00018	0.000839	CcSEcCtD
L-Carnitine—Cough—Triamcinolone—psoriasis	0.00018	0.000836	CcSEcCtD
L-Carnitine—Dyspnoea—Cyclosporine—psoriasis	0.000179	0.000833	CcSEcCtD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—CP—psoriasis	0.000179	0.00274	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000179	0.00083	CcSEcCtD
L-Carnitine—Convulsion—Triamcinolone—psoriasis	0.000179	0.00083	CcSEcCtD
L-Carnitine—Tachycardia—Prednisolone—psoriasis	0.000178	0.000829	CcSEcCtD
L-Carnitine—Asthenia—Mycophenolic acid—psoriasis	0.000178	0.000828	CcSEcCtD
L-Carnitine—Hypertension—Triamcinolone—psoriasis	0.000178	0.000827	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.000178	0.00272	CbGpPWpGaD
L-Carnitine—Infection—Hydrocortisone—psoriasis	0.000177	0.000824	CcSEcCtD
L-Carnitine—Insomnia—Mycophenolate mofetil—psoriasis	0.000177	0.000824	CcSEcCtD
L-Carnitine—Dyspepsia—Cyclosporine—psoriasis	0.000177	0.000822	CcSEcCtD
L-Carnitine—Nausea—Hydroxyurea—psoriasis	0.000176	0.000819	CcSEcCtD
L-Carnitine—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000176	0.000818	CcSEcCtD
L-Carnitine—Pruritus—Mycophenolic acid—psoriasis	0.000176	0.000817	CcSEcCtD
L-Carnitine—Myalgia—Triamcinolone—psoriasis	0.000175	0.000815	CcSEcCtD
L-Carnitine—Eye disorder—Prednisone—psoriasis	0.000175	0.000812	CcSEcCtD
L-Carnitine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000175	0.000812	CcSEcCtD
L-Carnitine—Decreased appetite—Cyclosporine—psoriasis	0.000175	0.000812	CcSEcCtD
L-Carnitine—Tachycardia—Hydrocortisone—psoriasis	0.000174	0.00081	CcSEcCtD
L-Carnitine—Depression—Methotrexate—psoriasis	0.000174	0.000807	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000173	0.000806	CcSEcCtD
L-Carnitine—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000173	0.000802	CcSEcCtD
L-Carnitine—Pain—Cyclosporine—psoriasis	0.000172	0.000799	CcSEcCtD
L-Carnitine—Constipation—Cyclosporine—psoriasis	0.000172	0.000799	CcSEcCtD
L-Carnitine—Renal failure—Methotrexate—psoriasis	0.000171	0.000795	CcSEcCtD
L-Carnitine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.00017	0.000792	CcSEcCtD
L-Carnitine—Anorexia—Hydrocortisone—psoriasis	0.00017	0.000791	CcSEcCtD
L-Carnitine—Diarrhoea—Mycophenolic acid—psoriasis	0.00017	0.00079	CcSEcCtD
L-Carnitine—Angiopathy—Prednisone—psoriasis	0.00017	0.000789	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000169	0.000786	CcSEcCtD
L-Carnitine—Vertigo—Dexamethasone—psoriasis	0.000168	0.000781	CcSEcCtD
L-Carnitine—Vertigo—Betamethasone—psoriasis	0.000168	0.000781	CcSEcCtD
L-Carnitine—Constipation—Mycophenolate mofetil—psoriasis	0.000168	0.000779	CcSEcCtD
L-Carnitine—Pain—Mycophenolate mofetil—psoriasis	0.000168	0.000779	CcSEcCtD
L-Carnitine—Arrhythmia—Prednisone—psoriasis	0.000167	0.000776	CcSEcCtD
L-Carnitine—Infection—Triamcinolone—psoriasis	0.000167	0.000776	CcSEcCtD
L-Carnitine—Hypotension—Hydrocortisone—psoriasis	0.000167	0.000775	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—NFKB1—psoriasis	0.000166	0.00255	CbGpPWpGaD
L-Carnitine—Insomnia—Prednisolone—psoriasis	0.000165	0.000769	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—JUN—psoriasis	0.000165	0.00253	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Cyclosporine—psoriasis	0.000164	0.000764	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—TP53—psoriasis	0.000164	0.00252	CbGpPWpGaD
L-Carnitine—Dizziness—Mycophenolic acid—psoriasis	0.000164	0.000763	CcSEcCtD
L-Carnitine—Paraesthesia—Prednisolone—psoriasis	0.000164	0.000763	CcSEcCtD
L-Carnitine—Tachycardia—Triamcinolone—psoriasis	0.000164	0.000763	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000163	0.000756	CcSEcCtD
L-Carnitine—Convulsion—Betamethasone—psoriasis	0.000162	0.000753	CcSEcCtD
L-Carnitine—Convulsion—Dexamethasone—psoriasis	0.000162	0.000753	CcSEcCtD
L-Carnitine—Insomnia—Hydrocortisone—psoriasis	0.000162	0.000751	CcSEcCtD
L-Carnitine—Hypertension—Betamethasone—psoriasis	0.000161	0.00075	CcSEcCtD
L-Carnitine—Hypertension—Dexamethasone—psoriasis	0.000161	0.00075	CcSEcCtD
L-Carnitine—Paraesthesia—Hydrocortisone—psoriasis	0.00016	0.000745	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.00016	0.000745	CcSEcCtD
L-Carnitine—Myalgia—Betamethasone—psoriasis	0.000159	0.00074	CcSEcCtD
L-Carnitine—Myalgia—Dexamethasone—psoriasis	0.000159	0.00074	CcSEcCtD
L-Carnitine—Abdominal pain—Cyclosporine—psoriasis	0.000159	0.000738	CcSEcCtD
L-Carnitine—Body temperature increased—Cyclosporine—psoriasis	0.000159	0.000738	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.000159	0.00244	CbGpPWpGaD
L-Carnitine—Anxiety—Betamethasone—psoriasis	0.000159	0.000737	CcSEcCtD
L-Carnitine—Anxiety—Dexamethasone—psoriasis	0.000159	0.000737	CcSEcCtD
L-Carnitine—Vomiting—Mycophenolic acid—psoriasis	0.000158	0.000734	CcSEcCtD
L-Carnitine—Dyspepsia—Hydrocortisone—psoriasis	0.000157	0.000731	CcSEcCtD
L-Carnitine—Haemoglobin—Methotrexate—psoriasis	0.000157	0.00073	CcSEcCtD
L-Carnitine—Rash—Mycophenolic acid—psoriasis	0.000157	0.000728	CcSEcCtD
L-Carnitine—Dermatitis—Mycophenolic acid—psoriasis	0.000156	0.000727	CcSEcCtD
L-Carnitine—Pain—Prednisolone—psoriasis	0.000156	0.000727	CcSEcCtD
L-Carnitine—Haemorrhage—Methotrexate—psoriasis	0.000156	0.000726	CcSEcCtD
L-Carnitine—Headache—Mycophenolic acid—psoriasis	0.000156	0.000723	CcSEcCtD
L-Carnitine—Decreased appetite—Hydrocortisone—psoriasis	0.000155	0.000721	CcSEcCtD
L-Carnitine—Pharyngitis—Methotrexate—psoriasis	0.000155	0.000721	CcSEcCtD
L-Carnitine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000155	0.00072	CcSEcCtD
L-Carnitine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000155	0.00072	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000154	0.000716	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000153	0.000712	CcSEcCtD
L-Carnitine—Pain—Hydrocortisone—psoriasis	0.000153	0.00071	CcSEcCtD
L-Carnitine—Insomnia—Triamcinolone—psoriasis	0.000152	0.000707	CcSEcCtD
L-Carnitine—Infection—Betamethasone—psoriasis	0.000152	0.000704	CcSEcCtD
L-Carnitine—Infection—Dexamethasone—psoriasis	0.000152	0.000704	CcSEcCtD
L-Carnitine—Paraesthesia—Triamcinolone—psoriasis	0.000151	0.000702	CcSEcCtD
L-Carnitine—Anaemia—Prednisone—psoriasis	0.00015	0.000699	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—IL6—psoriasis	0.00015	0.00231	CbGpPWpGaD
L-Carnitine—Dyspnoea—Triamcinolone—psoriasis	0.00015	0.000697	CcSEcCtD
L-Carnitine—Tachycardia—Dexamethasone—psoriasis	0.000149	0.000692	CcSEcCtD
L-Carnitine—Tachycardia—Betamethasone—psoriasis	0.000149	0.000692	CcSEcCtD
L-Carnitine—Hypersensitivity—Cyclosporine—psoriasis	0.000148	0.000688	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—TNF—psoriasis	0.000148	0.00227	CbGpPWpGaD
L-Carnitine—Dyspepsia—Triamcinolone—psoriasis	0.000148	0.000688	CcSEcCtD
L-Carnitine—Nausea—Mycophenolic acid—psoriasis	0.000148	0.000686	CcSEcCtD
L-Carnitine—Vertigo—Prednisone—psoriasis	0.000146	0.00068	CcSEcCtD
L-Carnitine—Eye disorder—Methotrexate—psoriasis	0.000146	0.000679	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000146	0.000679	CcSEcCtD
L-Carnitine—Anorexia—Betamethasone—psoriasis	0.000145	0.000676	CcSEcCtD
L-Carnitine—Anorexia—Dexamethasone—psoriasis	0.000145	0.000676	CcSEcCtD
L-Carnitine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000144	0.000671	CcSEcCtD
L-Carnitine—Asthenia—Cyclosporine—psoriasis	0.000144	0.00067	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—VEGFA—psoriasis	0.000144	0.00221	CbGpPWpGaD
L-Carnitine—Pain—Triamcinolone—psoriasis	0.000144	0.000668	CcSEcCtD
L-Carnitine—CROT—Metabolism—CAT—psoriasis	0.000143	0.0022	CbGpPWpGaD
L-Carnitine—Hypotension—Betamethasone—psoriasis	0.000143	0.000663	CcSEcCtD
L-Carnitine—Hypotension—Dexamethasone—psoriasis	0.000143	0.000663	CcSEcCtD
L-Carnitine—Pruritus—Cyclosporine—psoriasis	0.000142	0.000661	CcSEcCtD
L-Carnitine—Angiopathy—Methotrexate—psoriasis	0.000142	0.000659	CcSEcCtD
L-Carnitine—Body temperature increased—Hydrocortisone—psoriasis	0.000141	0.000656	CcSEcCtD
L-Carnitine—Abdominal pain—Hydrocortisone—psoriasis	0.000141	0.000656	CcSEcCtD
L-Carnitine—Convulsion—Prednisone—psoriasis	0.000141	0.000656	CcSEcCtD
L-Carnitine—XDH—Metabolism—NDUFA5—psoriasis	0.000141	0.00216	CbGpPWpGaD
L-Carnitine—Asthenia—Mycophenolate mofetil—psoriasis	0.000141	0.000654	CcSEcCtD
L-Carnitine—Hypertension—Prednisone—psoriasis	0.000141	0.000653	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000139	0.000646	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000139	0.000646	CcSEcCtD
L-Carnitine—Pruritus—Mycophenolate mofetil—psoriasis	0.000139	0.000644	CcSEcCtD
L-Carnitine—Myalgia—Prednisone—psoriasis	0.000139	0.000644	CcSEcCtD
L-Carnitine—Anxiety—Prednisone—psoriasis	0.000138	0.000642	CcSEcCtD
L-Carnitine—Insomnia—Betamethasone—psoriasis	0.000138	0.000641	CcSEcCtD
L-Carnitine—Insomnia—Dexamethasone—psoriasis	0.000138	0.000641	CcSEcCtD
L-Carnitine—Diarrhoea—Cyclosporine—psoriasis	0.000137	0.000639	CcSEcCtD
L-Carnitine—Paraesthesia—Dexamethasone—psoriasis	0.000137	0.000637	CcSEcCtD
L-Carnitine—Paraesthesia—Betamethasone—psoriasis	0.000137	0.000637	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000137	0.0021	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—CP—psoriasis	0.000136	0.00208	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—JUN—psoriasis	0.000135	0.00207	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Prednisolone—psoriasis	0.000135	0.000626	CcSEcCtD
L-Carnitine—Dyspepsia—Betamethasone—psoriasis	0.000134	0.000624	CcSEcCtD
L-Carnitine—Dyspepsia—Dexamethasone—psoriasis	0.000134	0.000624	CcSEcCtD
L-Carnitine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000134	0.000623	CcSEcCtD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—CP—psoriasis	0.000134	0.00205	CbGpPWpGaD
L-Carnitine—Dysgeusia—Methotrexate—psoriasis	0.000133	0.000619	CcSEcCtD
L-Carnitine—Body temperature increased—Triamcinolone—psoriasis	0.000133	0.000618	CcSEcCtD
L-Carnitine—Dizziness—Cyclosporine—psoriasis	0.000133	0.000618	CcSEcCtD
L-Carnitine—Decreased appetite—Dexamethasone—psoriasis	0.000133	0.000616	CcSEcCtD
L-Carnitine—Decreased appetite—Betamethasone—psoriasis	0.000133	0.000616	CcSEcCtD
L-Carnitine—Infection—Prednisone—psoriasis	0.000132	0.000613	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000132	0.000612	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Betamethasone—psoriasis	0.000132	0.000612	CcSEcCtD
L-Carnitine—Back pain—Methotrexate—psoriasis	0.000132	0.000612	CcSEcCtD
L-Carnitine—Hypersensitivity—Hydrocortisone—psoriasis	0.000132	0.000611	CcSEcCtD
L-Carnitine—Pain—Dexamethasone—psoriasis	0.00013	0.000606	CcSEcCtD
L-Carnitine—Pain—Betamethasone—psoriasis	0.00013	0.000606	CcSEcCtD
L-Carnitine—Tachycardia—Prednisone—psoriasis	0.00013	0.000603	CcSEcCtD
L-Carnitine—Dizziness—Mycophenolate mofetil—psoriasis	0.00013	0.000602	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—TNF—psoriasis	0.000129	0.00199	CbGpPWpGaD
L-Carnitine—Asthenia—Hydrocortisone—psoriasis	0.000128	0.000595	CcSEcCtD
L-Carnitine—Vomiting—Cyclosporine—psoriasis	0.000128	0.000594	CcSEcCtD
L-Carnitine—CPT2—Metabolism—CARM1—psoriasis	0.000128	0.00196	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—CARM1—psoriasis	0.000127	0.00196	CbGpPWpGaD
L-Carnitine—Rash—Cyclosporine—psoriasis	0.000127	0.000589	CcSEcCtD
L-Carnitine—Anorexia—Prednisone—psoriasis	0.000127	0.000589	CcSEcCtD
L-Carnitine—Dermatitis—Cyclosporine—psoriasis	0.000127	0.000588	CcSEcCtD
L-Carnitine—Pruritus—Hydrocortisone—psoriasis	0.000126	0.000587	CcSEcCtD
L-Carnitine—Headache—Cyclosporine—psoriasis	0.000126	0.000585	CcSEcCtD
L-Carnitine—Anaemia—Methotrexate—psoriasis	0.000126	0.000584	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Betamethasone—psoriasis	0.000125	0.00058	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Dexamethasone—psoriasis	0.000125	0.00058	CcSEcCtD
L-Carnitine—Vomiting—Mycophenolate mofetil—psoriasis	0.000125	0.000579	CcSEcCtD
L-Carnitine—Hypersensitivity—Triamcinolone—psoriasis	0.000124	0.000576	CcSEcCtD
L-Carnitine—Rash—Mycophenolate mofetil—psoriasis	0.000124	0.000574	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—TNF—psoriasis	0.000124	0.0019	CbGpPWpGaD
L-Carnitine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000123	0.000574	CcSEcCtD
L-Carnitine—Headache—Mycophenolate mofetil—psoriasis	0.000123	0.000571	CcSEcCtD
L-Carnitine—Vertigo—Methotrexate—psoriasis	0.000122	0.000568	CcSEcCtD
L-Carnitine—Diarrhoea—Hydrocortisone—psoriasis	0.000122	0.000568	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—CAT—psoriasis	0.000122	0.00187	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CAT—psoriasis	0.000122	0.00187	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Prednisone—psoriasis	0.000121	0.000563	CcSEcCtD
L-Carnitine—Dizziness—Prednisolone—psoriasis	0.000121	0.000562	CcSEcCtD
L-Carnitine—Asthenia—Triamcinolone—psoriasis	0.000121	0.000561	CcSEcCtD
L-Carnitine—Abdominal pain—Dexamethasone—psoriasis	0.000121	0.000561	CcSEcCtD
L-Carnitine—Abdominal pain—Betamethasone—psoriasis	0.000121	0.000561	CcSEcCtD
L-Carnitine—Body temperature increased—Betamethasone—psoriasis	0.000121	0.000561	CcSEcCtD
L-Carnitine—Body temperature increased—Dexamethasone—psoriasis	0.000121	0.000561	CcSEcCtD
L-Carnitine—Insomnia—Prednisone—psoriasis	0.00012	0.000558	CcSEcCtD
L-Carnitine—XDH—Metabolism—CYP2S1—psoriasis	0.00012	0.00184	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—IL6—psoriasis	0.000119	0.00183	CbGpPWpGaD
L-Carnitine—Nausea—Cyclosporine—psoriasis	0.000119	0.000555	CcSEcCtD
L-Carnitine—Paraesthesia—Prednisone—psoriasis	0.000119	0.000554	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.000119	0.00183	CbGpPWpGaD
L-Carnitine—Pruritus—Triamcinolone—psoriasis	0.000119	0.000553	CcSEcCtD
L-Carnitine—Cough—Methotrexate—psoriasis	0.000119	0.000552	CcSEcCtD
L-Carnitine—Dizziness—Hydrocortisone—psoriasis	0.000118	0.000549	CcSEcCtD
L-Carnitine—Convulsion—Methotrexate—psoriasis	0.000118	0.000548	CcSEcCtD
L-Carnitine—Dyspepsia—Prednisone—psoriasis	0.000117	0.000544	CcSEcCtD
L-Carnitine—Nausea—Mycophenolate mofetil—psoriasis	0.000116	0.000541	CcSEcCtD
L-Carnitine—Myalgia—Methotrexate—psoriasis	0.000116	0.000538	CcSEcCtD
L-Carnitine—Chest pain—Methotrexate—psoriasis	0.000116	0.000538	CcSEcCtD
L-Carnitine—Decreased appetite—Prednisone—psoriasis	0.000116	0.000537	CcSEcCtD
L-Carnitine—Rash—Prednisolone—psoriasis	0.000115	0.000536	CcSEcCtD
L-Carnitine—Dermatitis—Prednisolone—psoriasis	0.000115	0.000535	CcSEcCtD
L-Carnitine—Headache—Prednisolone—psoriasis	0.000115	0.000532	CcSEcCtD
L-Carnitine—Constipation—Prednisone—psoriasis	0.000114	0.000528	CcSEcCtD
L-Carnitine—Vomiting—Hydrocortisone—psoriasis	0.000114	0.000528	CcSEcCtD
L-Carnitine—Rash—Hydrocortisone—psoriasis	0.000113	0.000523	CcSEcCtD
L-Carnitine—Dermatitis—Hydrocortisone—psoriasis	0.000112	0.000523	CcSEcCtD
L-Carnitine—Headache—Hydrocortisone—psoriasis	0.000112	0.00052	CcSEcCtD
L-Carnitine—CROT—Metabolism—APOE—psoriasis	0.000111	0.00171	CbGpPWpGaD
L-Carnitine—Dizziness—Triamcinolone—psoriasis	0.000111	0.000517	CcSEcCtD
L-Carnitine—Infection—Methotrexate—psoriasis	0.00011	0.000513	CcSEcCtD
L-Carnitine—Asthenia—Dexamethasone—psoriasis	0.000109	0.000509	CcSEcCtD
L-Carnitine—Asthenia—Betamethasone—psoriasis	0.000109	0.000509	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Prednisone—psoriasis	0.000109	0.000505	CcSEcCtD
L-Carnitine—Nausea—Prednisolone—psoriasis	0.000109	0.000505	CcSEcCtD
L-Carnitine—Pruritus—Dexamethasone—psoriasis	0.000108	0.000502	CcSEcCtD
L-Carnitine—Pruritus—Betamethasone—psoriasis	0.000108	0.000502	CcSEcCtD
L-Carnitine—Vomiting—Triamcinolone—psoriasis	0.000107	0.000497	CcSEcCtD
L-Carnitine—Nausea—Hydrocortisone—psoriasis	0.000106	0.000493	CcSEcCtD
L-Carnitine—Rash—Triamcinolone—psoriasis	0.000106	0.000493	CcSEcCtD
L-Carnitine—Dermatitis—Triamcinolone—psoriasis	0.000106	0.000492	CcSEcCtD
L-Carnitine—Anorexia—Methotrexate—psoriasis	0.000106	0.000492	CcSEcCtD
L-Carnitine—Headache—Triamcinolone—psoriasis	0.000105	0.00049	CcSEcCtD
L-Carnitine—Abdominal pain—Prednisone—psoriasis	0.000105	0.000488	CcSEcCtD
L-Carnitine—Body temperature increased—Prednisone—psoriasis	0.000105	0.000488	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—IL6—psoriasis	0.000104	0.0016	CbGpPWpGaD
L-Carnitine—Diarrhoea—Betamethasone—psoriasis	0.000104	0.000485	CcSEcCtD
L-Carnitine—Diarrhoea—Dexamethasone—psoriasis	0.000104	0.000485	CcSEcCtD
L-Carnitine—Hypotension—Methotrexate—psoriasis	0.000104	0.000482	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000101	0.00047	CcSEcCtD
L-Carnitine—Dizziness—Dexamethasone—psoriasis	0.000101	0.000469	CcSEcCtD
L-Carnitine—Dizziness—Betamethasone—psoriasis	0.000101	0.000469	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—CP—psoriasis	0.0001	0.00154	CbGpPWpGaD
L-Carnitine—Insomnia—Methotrexate—psoriasis	0.0001	0.000467	CcSEcCtD
L-Carnitine—Nausea—Triamcinolone—psoriasis	9.99e-05	0.000464	CcSEcCtD
L-Carnitine—Paraesthesia—Methotrexate—psoriasis	9.97e-05	0.000463	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL6—psoriasis	9.97e-05	0.00153	CbGpPWpGaD
L-Carnitine—Dyspnoea—Methotrexate—psoriasis	9.9e-05	0.00046	CcSEcCtD
L-Carnitine—Hypersensitivity—Prednisone—psoriasis	9.79e-05	0.000455	CcSEcCtD
L-Carnitine—Dyspepsia—Methotrexate—psoriasis	9.78e-05	0.000454	CcSEcCtD
L-Carnitine—Vomiting—Betamethasone—psoriasis	9.7e-05	0.000451	CcSEcCtD
L-Carnitine—Vomiting—Dexamethasone—psoriasis	9.7e-05	0.000451	CcSEcCtD
L-Carnitine—CROT—Metabolism—PPARG—psoriasis	9.69e-05	0.00149	CbGpPWpGaD
L-Carnitine—Decreased appetite—Methotrexate—psoriasis	9.65e-05	0.000449	CcSEcCtD
L-Carnitine—Rash—Dexamethasone—psoriasis	9.62e-05	0.000447	CcSEcCtD
L-Carnitine—Rash—Betamethasone—psoriasis	9.62e-05	0.000447	CcSEcCtD
L-Carnitine—Dermatitis—Dexamethasone—psoriasis	9.61e-05	0.000447	CcSEcCtD
L-Carnitine—Dermatitis—Betamethasone—psoriasis	9.61e-05	0.000447	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Methotrexate—psoriasis	9.59e-05	0.000446	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—CARM1—psoriasis	9.58e-05	0.00147	CbGpPWpGaD
L-Carnitine—Headache—Betamethasone—psoriasis	9.56e-05	0.000444	CcSEcCtD
L-Carnitine—Headache—Dexamethasone—psoriasis	9.56e-05	0.000444	CcSEcCtD
L-Carnitine—Asthenia—Prednisone—psoriasis	9.53e-05	0.000443	CcSEcCtD
L-Carnitine—Pain—Methotrexate—psoriasis	9.5e-05	0.000441	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.49e-05	0.00146	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—APOE—psoriasis	9.46e-05	0.00145	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—APOE—psoriasis	9.46e-05	0.00145	CbGpPWpGaD
L-Carnitine—Pruritus—Prednisone—psoriasis	9.4e-05	0.000437	CcSEcCtD
L-Carnitine—Diarrhoea—Prednisone—psoriasis	9.09e-05	0.000422	CcSEcCtD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—CP—psoriasis	9.08e-05	0.00139	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Methotrexate—psoriasis	9.08e-05	0.000422	CcSEcCtD
L-Carnitine—Nausea—Betamethasone—psoriasis	9.06e-05	0.000421	CcSEcCtD
L-Carnitine—Nausea—Dexamethasone—psoriasis	9.06e-05	0.000421	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—psoriasis	8.89e-05	0.00137	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CARM1—psoriasis	8.84e-05	0.00136	CbGpPWpGaD
L-Carnitine—Dizziness—Prednisone—psoriasis	8.79e-05	0.000408	CcSEcCtD
L-Carnitine—Abdominal pain—Methotrexate—psoriasis	8.78e-05	0.000408	CcSEcCtD
L-Carnitine—Body temperature increased—Methotrexate—psoriasis	8.78e-05	0.000408	CcSEcCtD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—CARM1—psoriasis	8.67e-05	0.00133	CbGpPWpGaD
L-Carnitine—Vomiting—Prednisone—psoriasis	8.45e-05	0.000393	CcSEcCtD
L-Carnitine—Rash—Prednisone—psoriasis	8.38e-05	0.000389	CcSEcCtD
L-Carnitine—Dermatitis—Prednisone—psoriasis	8.37e-05	0.000389	CcSEcCtD
L-Carnitine—Headache—Prednisone—psoriasis	8.32e-05	0.000387	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.26e-05	0.00127	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PPARG—psoriasis	8.24e-05	0.00126	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PPARG—psoriasis	8.24e-05	0.00126	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Methotrexate—psoriasis	8.18e-05	0.00038	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—IL6—psoriasis	8.14e-05	0.00125	CbGpPWpGaD
L-Carnitine—Asthenia—Methotrexate—psoriasis	7.97e-05	0.00037	CcSEcCtD
L-Carnitine—Nausea—Prednisone—psoriasis	7.89e-05	0.000367	CcSEcCtD
L-Carnitine—Pruritus—Methotrexate—psoriasis	7.86e-05	0.000365	CcSEcCtD
L-Carnitine—CPT2—Metabolism—CAT—psoriasis	7.84e-05	0.0012	CbGpPWpGaD
L-Carnitine—Diarrhoea—Methotrexate—psoriasis	7.6e-05	0.000353	CcSEcCtD
L-Carnitine—SLCO1B1—Metabolism—NDUFA5—psoriasis	7.42e-05	0.00114	CbGpPWpGaD
L-Carnitine—Dizziness—Methotrexate—psoriasis	7.34e-05	0.000341	CcSEcCtD
L-Carnitine—Vomiting—Methotrexate—psoriasis	7.06e-05	0.000328	CcSEcCtD
L-Carnitine—Rash—Methotrexate—psoriasis	7e-05	0.000325	CcSEcCtD
L-Carnitine—Dermatitis—Methotrexate—psoriasis	7e-05	0.000325	CcSEcCtD
L-Carnitine—Headache—Methotrexate—psoriasis	6.96e-05	0.000323	CcSEcCtD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.92e-05	0.00106	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—CP—psoriasis	6.9e-05	0.00106	CbGpPWpGaD
L-Carnitine—Nausea—Methotrexate—psoriasis	6.6e-05	0.000307	CcSEcCtD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—CARM1—psoriasis	6.58e-05	0.00101	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP2S1—psoriasis	6.31e-05	0.000969	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—APOE—psoriasis	6.09e-05	0.000936	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CARM1—psoriasis	5.86e-05	0.000899	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CAT—psoriasis	5.44e-05	0.000835	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PPARG—psoriasis	5.31e-05	0.000815	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—APOE—psoriasis	4.22e-05	0.000649	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PPARG—psoriasis	3.68e-05	0.000565	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CAT—psoriasis	3.6e-05	0.000553	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.31e-05	0.000508	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CARM1—psoriasis	3.08e-05	0.000473	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.88e-05	0.000442	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—APOE—psoriasis	2.8e-05	0.00043	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PPARG—psoriasis	2.44e-05	0.000374	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CAT—psoriasis	1.9e-05	0.000291	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—APOE—psoriasis	1.47e-05	0.000226	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PPARG—psoriasis	1.28e-05	0.000197	CbGpPWpGaD
